Interstitial Lung Disease: What Rheumatologists Need to Know

In the past decade, the treat-to-target concept has gained broad acceptance. Both the ACR and European League Against Rheumatism (EULAR) management recommendations include adding biologic therapies to the treatment regimen for rheumatoid arthritis (RA) patients who do not sufficiently respond to methotrexate monotherapy. “What EULAR says is that if [metho­trexate use fails], you should essentially... [Read More]
Source: The Rheumatologist - Category: Rheumatology Authors: Tags: Conditions Interstitial Lung Disease Source Type: research